Atticus Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Atticus Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$705.89 - $766.39 $4,235 - $4,598	-6 Reduced 66.67%	3 $2,000
Q1 2022 Apr 15, 2022	BUY	$595.12 - $698.43 $2,380 - $2,793	4 Added 80.0%	9 $6,000
Q4 2021 Jan 26, 2022	SELL	$543.48 - $670.97 $33,152 - $40,929	-61 Reduced 92.42%	5 $3,000
Q3 2021 Oct 18, 2021	SELL	$574.03 - $680.96 $1,148 - $1,361	-2 Reduced 2.94%	66 $40,000
Q1 2021 Apr 15, 2021	SELL	$446.73 - $548.2 $25,910 - $31,795	-58 Reduced 46.03%	68 $32,000
Q2 2020 Jul 15, 2020	BUY	$493.32 - $643.92 $1,479 - $1,931	3 Added 2.44%	126 $79,000
Q1 2020 Apr 23, 2020	BUY	$336.18 - $494.43 $41,350 - $60,814	123 New	123 $60,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Atticus Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Atticus Wealth Management, LLC with notifications on news.